Curriculum vitae Aria Baniahmad, Univ.-Prof. Dr. rer. nat. habil. Position: Professor, Vice Head, Department of Human Genetics, Jena University Hospital Address: Institute of Human Genetics, Jena University Hospital, Am Klinikum 1, 07740 Jena, Germany Private data: German citizen; born in Stuttgart, Germany; 3 children Education 1980 - 1985 Studies in Biology at Universities Würzburg and Stuttgart 1986 Diploma work (M.Sc.) at the Max-Planck-Institute of Biochemistry, Gene Center, Martinsried, Munich, Germany 1987 - 1990 PhD thesis at the Max-Planck-Institute of Biochemistry, Gene Center, Martinsried, Munich („summa cum laude“) 1990 - 1991 Postdoc at the Max-Planck-Institute of Biochemistry, Gene Center, Martinsried, Munich, Germany 1991 - 1993 Postdoctoral Scientist and Research Associate at the Baylor College of Medicine, Houston, USA 1994 Postdoc at the Institute for Molecular Biology and Tumour Genetics, Marburg, Germany 1995 - 2004 Group leader at the Institute of Genetics, University of Giessen, Germany 1999 Habilitation in Molecular Biology and Genetics since 2004 Professor for Molecular Genetics, University of Jena, Germany 2005 - 2007 Professorship for Biochemistry, University Kuopio, Finland 2008 - 2010 Provisional head of the Institute of Human Genetics since 2010 Vice Director of the Institute of Human Genetics, Jena University Hospital, Germany Research Topic: Analyses of androgen receptor signaling in prostate cancer. Molecular analysis of mechanisms of therapy resistance of prostate cancer. Selected 5 topic-relevant publications: Ehsani M, Bartsch S, Rasa SMM, Dittmann J, Pungsrinont T, Neubert L, Huettner SS, Kotolloshi R, Schindler K, Ahmad A, Mosig AS, Adam L, Ori A, Neri F, Berndt A, Grimm M-O, Baniahmad A. The natural compound atraric acid suppresses androgen-regulated neo-angiogenesis of castration-resistant prostate cancer through angiopoietin 2. Oncogene. 2022;41(23):3263-3277. Mirzakhani K, Kallenbach J, Rasa SMM, Ribaudo F, Ungelenk M, Ehsani M, Gong W, Gassler N, Leeder M, Grimm MO, Neri F, Baniahmad A. The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells. Oncogene. 2022;41(7):943-959. Bartsch S, Mirzakhani K, Neubert L, Stenzel A, Ehsani M, Esmaeili M, Pungsrinont T, Kacal M, Rasa SMM, Kallenbach J, Damodaran D, Ribaudo F, Grimm MO, Neri F, Baniahmad A. Antithetic hTERT Regulation by Androgens in Prostate Cancer Cells: hTERT Inhibition Is Mediated by the ING1 and ING2 Tumor Suppressors. Cancers (Basel). 2021;13(16):4025. Pungsrinont T, Sutter MF, Ertingshausen MCCM, Lakshmana G, Kokal M, Khan AS, Baniahmad A. Senolytic compounds control a distinct fate of androgen receptor agonist- and antagonist-induced cellular senescent LNCaP prostate cancer cells. Cell Biosci. 2020;10:59. Obtained the MK Jeang Award for Excellence in Cell & Bioscience, Springer Nature. Roediger J, Hessenkemper W, Bartsch S, Manvelyan M, Huettner SS, Liehr T, Esmaeili M, Foller S, Petersen I, Grimm MO, Baniahmad A. Supraphysiological androgen levels induce cellular senescence in human prostate cancer cells through the Src-Akt pathway. Mol Cancer. 2014;12;13:214.